These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3018893)

  • 41. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
    Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
    Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
    Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.
    Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS
    N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfusion-associated acquired immunodeficiency syndrome in the United States.
    Peterman TA; Jaffe HW; Feorino PM; Getchell JP; Warfield DT; Haverkos HW; Stoneburner RL; Curran JW
    JAMA; 1985 Nov 22-29; 254(20):2913-7. PubMed ID: 2997493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome.
    Groopman JE; Sarngadharan MG; Salahuddin SZ; Buxbaum R; Huberman MS; Kinniburgh J; Sliski A; McLane MF; Essex M; Gallo RC
    Ann Intern Med; 1985 Jan; 102(1):63-6. PubMed ID: 2981497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HTLV-III/LAV infection in hemodialysis patients.
    Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR
    JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.
    Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC
    Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
    Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC
    Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second meeting of the WHO Collaborating Centres on AIDS: Memorandum from a WHO meeting.
    Bull World Health Organ; 1986; 64(1):37-46. PubMed ID: 3015444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human T-lymphotropic virus type III infection in previously immunocompromised hosts.
    Groopman JE; Hammer SM; Sallan SE; Allan JD
    J Clin Oncol; 1986 Apr; 4(4):540-3. PubMed ID: 3007685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cluster of HTLV-III/LAV infection in an African family.
    Jonckheer T; Dab I; Van de Perre P; Lepage P; Dasnoy J; Taelman H
    Lancet; 1985 Feb; 1(8425):400-1. PubMed ID: 2857454
    [No Abstract]   [Full Text] [Related]  

  • 52. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.
    Sullivan JL; Brewster FE; Brettler DB; Forsberg AD; Cheeseman SH; Byron KS; Baker SM; Willitts DL; Lew RA; Levine PH
    J Pediatr; 1986 Apr; 108(4):504-10. PubMed ID: 3007715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The epidemiology of AIDS: current status and future prospects.
    Curran JW; Morgan WM; Hardy AM; Jaffe HW; Darrow WW; Dowdle WR
    Science; 1985 Sep; 229(4720):1352-7. PubMed ID: 2994217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
    Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
    Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Properties and transmission of the AIDS virus].
    Laufs R
    Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous loss of HBeAg and the prevalence of HTLV-III/LAV infection in a cohort of homosexual hepatitis B virus carriers and the implications for antiviral therapy.
    Weller IV; Brown A; Morgan B; Hawkins A; Briggs M; Waite J; Cameron CH; Tedder R
    J Hepatol; 1986; 3 Suppl 2():S9-16. PubMed ID: 3298414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.